SCHEMBL14396540

SCHEMBL14396540

C=C1CCC2C3C(CCC12C)c1ccc(O)cc1C[C@@H]3C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.48
HSD17B1 P14061 6/20 0.48
ESR2 Q92731 6/20 0.48
HSD17B10 Q99714 4/20 0.48
SHBG P04278 4/20 0.48
LMNA P02545 4/20 0.48
STS P08842 3/20 0.48
PGR P06401 3/20 0.48
SERPINA6 P08185 3/20 0.48
AR P10275 3/20 0.48
SLC6A4 P31645 3/20 0.48
SNCA P37840 3/20 0.48
SLC6A3 Q01959 3/20 0.48
HIF1A Q16665 3/20 0.48
AKR1B10 O60218 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
MAPT P10636 2/20 0.48
AKR1B1 P15121 2/20 0.48
HTR2B P41595 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Almestrone SCHEMBL12364346 0.87 CYP19A1 (0.65) ESR1HSD17B1ESR2HSD17B10SHBG
Almestrone SCHEMBL8089798 0.87 CYP19A1 (0.65) ESR1HSD17B1ESR2HSD17B10SHBG
Almestrone SCHEMBL5983577 0.87 CYP19A1 (0.65) ESR1HSD17B1ESR2HSD17B10SHBG
Almestrone SCHEMBL12364585 0.87 CYP19A1 (0.65) ESR1HSD17B1ESR2HSD17B10SHBG
Almestrone SCHEMBL13216952 0.87 CYP19A1 (0.65) ESR1HSD17B1ESR2HSD17B10SHBG
Almestrone SCHEMBL1657631 0.87 CYP19A1 (0.65) ESR1HSD17B1ESR2HSD17B10SHBG
SCHEMBL6466520 0.85 LMNA (0.51) ESR1HSD17B1ESR2HSD17B10LMNA
SCHEMBL8088717 0.85 ESR1 (0.46) ESR1HSD17B1ESR2HSD17B10SHBG
Almestrone SCHEMBL2244882 0.84 CYP19A1 (0.61) ESR1HSD17B1ESR2HSD17B10SHBG
SCHEMBL25863903 0.79 ESR1 (0.49) ESR1ESR2HSD17B10SHBGLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1847548-A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use Sri International (US) 2007-10-24 EP disclosed